Test Price
900 AED✅ Home Collection Available
hTERT RNA Qualitative Detection (qPCR) in UAE – 900 AED – DHA Licensed Oncology Molecular Screening
Executive Summary & Core Metrics
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited qPCR Processing.
- Specimen Collection: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by a qualified specialist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview: This qualitative molecular assay detects human telomerase reverse transcriptase (hTERT) mRNA in clinical specimens using real-time quantitative PCR (qPCR), providing a sensitive biomarker for oncological screening and telomerase activity assessment.
Test Overview & Methodology
The hTERT RNA qualitative test employs real-time PCR (qPCR) with TaqMan probe chemistry to detect telomerase reverse transcriptase mRNA expression. The assay achieves a diagnostic sensitivity of 99.9% and is validated under ISO 9001:2015 standards. This molecular test is indicated for screening of malignancies—particularly in urological, pancreatic, and hematological contexts—and for evaluating telomerase activity as an anti-aging biomarker. Results must be integrated with full clinical history, imaging studies, and complementary laboratory markers for definitive diagnosis.
| Feature | Our Test (hTERT qPCR) | Standard hTERT RT-PCR |
|---|---|---|
| Precision | 99.9% Diagnostic Sensitivity | ~95% Sensitivity |
| Methodology | Real-Time PCR (qPCR) with ISO 9001:2015 Validation | Conventional RT-PCR |
| Turnaround Time | Results by Email: 36 hours; Phone: 24 hours | 5–7 working days |
Physician Insight & Safety Protocols
“The hTERT RNA qualitative assay provides valuable molecular information regarding telomerase activity, which can serve as an adjunctive biomarker in oncological screening. However, a positive result does not confirm malignancy; it warrants correlation with clinical presentation, imaging, histopathology, and other laboratory parameters. Do not alter or discontinue any prescribed medication without consulting your treating physician.” — Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
Advisory Notice
Medication Caution
Do not discontinue any prescribed medication without prior discussion with your treating physician. This test result should never be used as the sole basis for therapeutic decisions.
Exclusion Criteria & Emergency Red Flags
- Active infection at the intended sample collection site.
- Severe coagulopathy or ongoing anticoagulant therapy (for bone marrow aspiration).
- Pregnancy (relative contraindication for invasive procedures – consult your physician).
- Inability to provide informed consent.
Seek emergency care immediately if you experience:
- Heavy bleeding or expanding hematoma after bone marrow aspiration.
- Fever ≥38.5°C, chills, or severe pain at the collection site.
- Signs of anaphylaxis: difficulty breathing, facial swelling, hives.
Patient FAQ & Clinical Guidance
1. What is the hTERT RNA qualitative test and why is it performed?
The hTERT RNA qualitative test detects messenger RNA (mRNA) of the human telomerase reverse transcriptase gene using real-time qPCR. Telomerase activation is a hallmark of many cancers, making hTERT a valuable biomarker for early malignancy screening—particularly in urine for bladder cancer, pancreatic juice for pancreatic cancer, and bone marrow for hematological neoplasms. The test also assesses telomerase activity in anti-aging evaluations.
2. How is the sample collected and what types are accepted?
Acceptable specimen types include urine, pancreatic juice, and bone marrow aspirate. Urine collection is non-invasive. Bone marrow aspiration is an invasive procedure that must be performed by a qualified physician under sterile conditions within an accredited hospital facility. Due to the requirement for bone marrow aspiration, all sample collections for this test are conducted strictly within a hospital setting; mobile home phlebotomy is not available.
3. How accurate is the hTERT RNA qualitative test?
The test achieves a diagnostic sensitivity of 99.9% using real-time PCR (qPCR) with ISO 9001:2015 accreditation, ensuring exceptional precision and reproducibility. False-negative results are extremely rare when pre-analytical sample handling and transport conditions are strictly followed. The test is performed in a CAP-accredited laboratory environment.
4. How do I interpret a positive hTERT result?
A positive hTERT RNA result indicates detectable telomerase reverse transcriptase mRNA in the specimen. This finding is suggestive but not diagnostic of malignancy. It must be interpreted alongside full clinical history, imaging studies, histopathological examination, and other biomarker assays. Always discuss results with your referring physician for comprehensive clinical correlation.
5. What is the turnaround time for results?
Results are available via email within 36 hours and by phone within 24 hours from sample receipt at the laboratory. Urgent clinical cases may be expedited upon request.
UAE Regulatory & Data Privacy Adherence
✓ This service fully complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. DHA Facility License: 1143. Laboratory: DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. ISO 9001:2015 Certified.
Clinical & Logistical Metadata
| Test Name | hTERT RNA Qualitative Detection (qPCR) |
| Price (AED) | 900 |
| Turnaround Time | Results by Email: 36 hours; Phone: 24 hours |
| Sample Type / Matrix | Bone Marrow Aspirate, Urine, Pancreatic Juice |
| Methodology Used | Real-Time PCR (qPCR) – TaqMan Probe Chemistry |
| ICD-10-CM Code | Z12.9 |
| LOINC Code | 101497-1 |
| DHA Facility License & Laboratory Address | License No: 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians